| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/27/2006 | WO2005108427A3 Method for producing soluble mhc proteins |
| 04/27/2006 | WO2005105157A3 INHIBITION OF HAIRLESS PROTEIN mRNA |
| 04/27/2006 | WO2005103251A3 Cancer specific promoters |
| 04/27/2006 | WO2005100544A3 SMALL RNAs AND BACTERIAL STRAINS INVOLVED IN QUORUM SENSING |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |
| 04/27/2006 | WO2005097202A3 Use of serum albumin binding peptides conjugates for the preparation of a medicament |
| 04/27/2006 | WO2005095457A3 Immunoglobulins |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005086825A3 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion |
| 04/27/2006 | WO2005085285A3 Nuclear hormone receptors |
| 04/27/2006 | WO2005080581A3 Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| 04/27/2006 | WO2005080578A3 Desaturase enzymes |
| 04/27/2006 | WO2005079815A3 Methods and reagents for treating autosomal dominant diseases of the eye |
| 04/27/2006 | WO2005059157A3 METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs |
| 04/27/2006 | WO2005049789A3 Synthetic mammalian retrotransposon gene |
| 04/27/2006 | WO2005034853A3 Uses of interferons with altered spatial structure |
| 04/27/2006 | WO2005001896A3 Wet chemical processing chambers for processing microfeature workpieces |
| 04/27/2006 | WO2004094592A3 Polymer-conjugated glycosylated neublastin |
| 04/27/2006 | WO2004085624A3 Transaminases, deaminases and aminomutases and compositions and methods for enzymatic detoxification |
| 04/27/2006 | WO2004083454A3 Wheel motion control input device for animation system |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | WO2003033665A3 Secreted protein, ztnf9 |
| 04/27/2006 | US20060090225 Wheat variety YW03W |
| 04/27/2006 | US20060090224 Cotton cultivar DP 6226 BG/RR Acala |
| 04/27/2006 | US20060090223 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 04/27/2006 | US20060090222 Nucleic acid sequence functionally associated with a promoter, used to modify the natural formation of triacylglycerols in plants to increase the yield of commercial plant oils, or to modify their composition to achieve specific commercial improvements of plants and plant products; Arabidopsis |
| 04/27/2006 | US20060090221 Transgenic plant or a yeast cell containing recombinant nucleic acid having a promoter sequence linked to a heterologous nucleic acid that hybridizes under high-stringency conditions with a specific nucleic acid probe and encodes a protein having Delta 8 fatty acid desaturase activity |
| 04/27/2006 | US20060090220 Nucleotide sequences coding insecticidal for use in biological pest control; larvicides; growth inhibiting effect |
| 04/27/2006 | US20060090219 Methods for producing plants with improved growth under nitrogen-limited conditions |
| 04/27/2006 | US20060090218 Method of controlling gene expression and gene silencing |
| 04/27/2006 | US20060090217 Isolation of proteins involved in posttranscriptional gene silencing and methods of use |
| 04/27/2006 | US20060090216 Promoter, promoter control elements, and combinations, and uses thereof |
| 04/27/2006 | US20060090215 Low allergen plant and animal genotypes |
| 04/27/2006 | US20060090214 Method of treatment and an animal model useful for same |
| 04/27/2006 | US20060090213 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions |
| 04/27/2006 | US20060090212 Novel human genes and proteins encoded thereby |
| 04/27/2006 | US20060089523 Embryo modification and implantation |
| 04/27/2006 | US20060089492 DNA comprising promoter sequence, derived from a wild-type promoter of a methyltrophic yeast, whose transcription efficiency is modulated in comparison to the efficiency of the wild-type promoter by inserting or modifying a DNA binding site |
| 04/27/2006 | US20060089490 Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophy |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089324 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| 04/27/2006 | US20060089323 RNA interference; respiratory syncytial virus (RSV), parainfluenza virus (PIV) |
| 04/27/2006 | US20060089322 Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies |
| 04/27/2006 | US20060089320 Modulation of type IIß phosphoinositide phosphate kinase |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089299 Selective treatment of endothelial somatostatin receptors |
| 04/27/2006 | US20060089283 Pectate lyase variants |
| 04/27/2006 | US20060088938 Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants |
| 04/27/2006 | US20060088937 Flavivirus expression and delivery system |
| 04/27/2006 | US20060088936 Raav expression systems for genetic modification of specific capsid proteins |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088931 Thermal cycling system and vessel therefor |
| 04/27/2006 | US20060088920 DNA comprising a nucleotide sequence that encodes decaprenyl diphosphate (DPP) synthase |
| 04/27/2006 | US20060088918 Phosphorylation activity for various types of nucleoside 5'-monophosphate other than AMP and deoxynucleoside 5'-monophosphate, and this enables production of various types of nucleoside 5'-diphosphate and deoxynucleoside 5'-diphosphate by an enzymatic procedure |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088911 Yeast transformation system |
| 04/27/2006 | US20060088910 RT-PCR-based cloning of the human beta-amyloid precursor protein gene and the construction of its expression plasmids |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088903 Method for the production of zymosterol and/or the biosynthetic intermediate and/or subsequent products thereof in transgenic organisms |
| 04/27/2006 | US20060088902 Methods and materials for the identification of antifungal substrates in filamentous fungi |
| 04/27/2006 | US20060088898 Methods for the production of cells and mammals with desired genetic modifications |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088880 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 04/27/2006 | US20060088879 DNA polymerases having improved labeled nucleotide incorporation properties |
| 04/27/2006 | US20060088878 Purification of recombinant proteins fused to multiple epitopes |
| 04/27/2006 | US20060088877 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX |
| 04/27/2006 | US20060088874 Methods and kits for detecting mutations |
| 04/27/2006 | US20060088866 Quantitative methylation detection in DNA samples |
| 04/27/2006 | US20060088864 Aptamer regulated nucleic acids and uses thereof |
| 04/27/2006 | US20060088859 Reporter assay screens for protein targets in Saccharomyces cerevisiae |
| 04/27/2006 | US20060088855 Methods of using FET labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same |
| 04/27/2006 | US20060088842 RT-PCR-based cloning of human SMN, the SMA determining gene, and the construction of its expression plasmids |
| 04/27/2006 | US20060088841 Reversible, parallel and multitask cloning method and kit |
| 04/27/2006 | US20060088839 Involving monitoring outputs from nucleic acid probe parts due to hybridization between a nucleic acid probe and the specific nucleic acid to determine frequency distribution of times when the outputs exceed a predetermined value with respect to each of the probes parts |
| 04/27/2006 | US20060088837 Expression system for stem-loop rna molecule having rnai effect |
| 04/27/2006 | US20060088836 Methods and compositions for diagnosing and monitoring transplant rejection |
| 04/27/2006 | US20060088835 Schizophrenia associated genes |
| 04/27/2006 | US20060088834 Matrix analysis of gene expression in cells (magec) |
| 04/27/2006 | US20060088832 Tap-70, a novel marker for epithelial tumors |
| 04/27/2006 | US20060088827 Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseases |
| 04/27/2006 | US20060088825 Human delta-n p73 molecules and uses thereof |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088821 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088819 Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
| 04/27/2006 | US20060088599 Amino functionalized ORMOSIL nanoparticles as delivery vehicles |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 04/27/2006 | US20060088547 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 04/27/2006 | US20060088546 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088531 Human antibodies against human glycoprotein VI and their use |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088526 Humanized anti-CD3 specific antibodies |
| 04/27/2006 | US20060088504 Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
| 04/27/2006 | DE3844959B4 New recombinant Escherichia coli strain - used for producing L-threonine |
| 04/27/2006 | DE10346611B4 Promotor zur epidermisspezifischen Transgenexpression in Pflanzen Promoter for transgene expression in plants epidermis |